SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-22-000037
Filing Date
2022-05-10
Accepted
2022-05-10 16:15:38
Documents
15
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20220510.htm   iXBRL 8-K 39830
2 EX-99.1 q12022financialresultsrele.htm EX-99.1 82557
6 GRAPHIC tcda-20220510_g1.jpg GRAPHIC 34563
7 GRAPHIC tricidalogoa03.jpg GRAPHIC 6561
  Complete submission text file 0001595585-22-000037.txt   367301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20220510.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20220510_lab.xml EX-101.LAB 25149
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20220510_pre.xml EX-101.PRE 13056
9 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20220510_htm.xml XML 11452
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 22909805
SIC: 2834 Pharmaceutical Preparations